• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

STXBP5 和 STX2 基因变异对 1 型血管性血友病患者血管性血友病因子和出血表型的影响。

Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.

机构信息

Department of Haematology, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

PLoS One. 2012;7(7):e40624. doi: 10.1371/journal.pone.0040624. Epub 2012 Jul 6.

DOI:10.1371/journal.pone.0040624
PMID:22792389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3391281/
Abstract

BACKGROUND

In type 1 von Willebrand Disease (VWD) patients, von Willebrand Factor (VWF) levels and bleeding symptoms are highly variable. Recently, the association between genetic variations in STXBP5 and STX2 with VWF levels has been discovered in the general population. We assessed the relationship between genetic variations in STXBP5 and STX2, VWF levels, and bleeding phenotype in type 1 VWD patients.

METHODS

In 158 patients diagnosed with type 1 VWD according to the current ISTH guidelines, we genotyped three tagging-SNPs in STXBP5 and STX2 and analyzed their relationship with VWF:Ag levels and the severity of the bleeding phenotype, as assessed by the Tosetto bleeding score.

RESULTS

In STX2, rs7978987 was significantly associated with VWF:Ag levels (bèta-coefficient (β) = -0.04 IU/mL per allele, [95%CI -0.07;-0.001], p = 0.04) and VWF:CB activity (β = -0.12 IU/mL per allele, [95%CI -0.17;-0.06], p<0.0001). For rs1039084 in STXBP5 a similar trend with VWF:Ag levels was observed: (β = -0.03 IU/mL per allele [95% CI -0.06;0.003], p = 0.07). In women, homozygous carriers of the minor alleles of both SNPs in STXBP5 had a significantly higher bleeding score than homozygous carriers of the major alleles. (Rs1039084 p = 0.01 and rs9399599 p = 0.02).

CONCLUSIONS

Genetic variation in STX2 is associated with VWF:Ag levels in patients diagnosed with type 1 VWD. In addition, genetic variation in STXBP5 is associated with bleeding phenotype in female VWD patients. Our findings may partly explain the variable VWF levels and bleeding phenotype in type 1 VWD patients.

摘要

背景

在 1 型血管性血友病(VWD)患者中,血管性血友病因子(VWF)水平和出血症状存在高度变异性。最近,在普通人群中发现了 STXBP5 和 STX2 中的遗传变异与 VWF 水平之间的关联。我们评估了 158 例根据当前 ISTH 指南诊断为 1 型 VWD 的患者中 STXBP5 和 STX2 中的遗传变异与 VWF 水平和出血表型之间的关系,出血表型的严重程度通过 Tosetto 出血评分进行评估。

方法

在 158 例根据当前 ISTH 指南诊断为 1 型 VWD 的患者中,我们对 STXBP5 和 STX2 中的三个标记 SNP 进行基因分型,并分析它们与 VWF:Ag 水平和出血表型严重程度之间的关系,出血表型的严重程度通过 Tosetto 出血评分进行评估。

结果

在 STX2 中,rs7978987 与 VWF:Ag 水平显著相关(β系数(β)=-0.04 IU/mL 每等位基因,[95%CI -0.07;-0.001],p=0.04)和 VWF:CB 活性(β=-0.12 IU/mL 每等位基因,[95%CI -0.17;-0.06],p<0.0001)。对于 STXBP5 中的 rs1039084,也观察到与 VWF:Ag 水平相似的趋势:(β=-0.03 IU/mL 每等位基因[95%CI -0.06;0.003],p=0.07)。在女性中,这两个 SNP 的 minor 等位基因纯合携带者的出血评分明显高于 major 等位基因纯合携带者。(rs1039084 p=0.01,rs9399599 p=0.02)。

结论

STX2 中的遗传变异与诊断为 1 型 VWD 的患者的 VWF:Ag 水平相关。此外,STXBP5 中的遗传变异与女性 VWD 患者的出血表型相关。我们的发现可能部分解释了 1 型 VWD 患者中 VWF 水平和出血表型的变异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b80/3391281/34961fa49cd5/pone.0040624.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b80/3391281/414e42b849aa/pone.0040624.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b80/3391281/34961fa49cd5/pone.0040624.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b80/3391281/414e42b849aa/pone.0040624.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b80/3391281/34961fa49cd5/pone.0040624.g002.jpg

相似文献

1
Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.STXBP5 和 STX2 基因变异对 1 型血管性血友病患者血管性血友病因子和出血表型的影响。
PLoS One. 2012;7(7):e40624. doi: 10.1371/journal.pone.0040624. Epub 2012 Jul 6.
2
CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.CLEC4M 和 STXBP5 基因突变可导致血管性血友病患者 von Willebrand 因子水平的变化。
J Thromb Haemost. 2015 Jun;13(6):956-66. doi: 10.1111/jth.12927. Epub 2015 May 9.
3
Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.Syntaxin结合蛋白5和Syntaxin-2基因变异对血管性血友病因子浓度及心血管风险的影响。
Circ Cardiovasc Genet. 2010 Dec;3(6):507-12. doi: 10.1161/CIRCGENETICS.110.957407.
4
Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients.1 型血管性血友病患者中Syntaxin 结合蛋白 STXBP5 的遗传变异。
Thromb Haemost. 2018 Aug;118(8):1382-1389. doi: 10.1055/s-0038-1661352. Epub 2018 Jul 4.
5
Performance related factors are the main determinants of the von Willebrand factor response to exhaustive physical exercise.与表现相关的因素是血管性血友病因子对力竭性体育锻炼反应的主要决定因素。
PLoS One. 2014 Mar 13;9(3):e91687. doi: 10.1371/journal.pone.0091687. eCollection 2014.
6
Associations of multiple genetic variations with plasma levels of Von Willebrand Factor and clinical phenotype in Iranian patients with Von Willebrand disease type 1.伊朗 1 型血管性血友病患者多种遗传变异与血管性血友病因子血浆水平及临床表型的相关性。
Transfus Apher Sci. 2023 Oct;62(5):103766. doi: 10.1016/j.transci.2023.103766. Epub 2023 Jul 27.
7
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.成年中重度血管性血友病患者出血表型的决定因素。
Thromb Haemost. 2012 Oct;108(4):683-92. doi: 10.1160/TH12-04-0244. Epub 2012 Aug 23.
8
Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.1型血管性血友病患者血管性血友病因子水平及血管性血友病活性随年龄的变化
Haemophilia. 2015 Sep;21(5):636-41. doi: 10.1111/hae.12664. Epub 2015 Mar 10.
9
Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.与较高 von Willebrand 因子 (VWF) 水平相关的合并症可能解释了 von Willebrand 病中 VWF 随年龄增长而增加的原因。
Br J Haematol. 2018 Jul;182(1):93-105. doi: 10.1111/bjh.15277. Epub 2018 May 16.
10
Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.通过小鼠体内的CRISPR/Cas9基因编辑揭示人STXBP5中一个单核苷酸多态性的新型血栓形成功能
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):264-270. doi: 10.1161/ATVBAHA.116.308614. Epub 2016 Dec 29.

引用本文的文献

1
Tomosyns attenuate SNARE assembly and synaptic depression by binding to VAMP2-containing template complexes.汤姆辛通过与包含 VAMP2 的模板复合物结合来减弱 SNARE 组装和突触抑制。
Nat Commun. 2024 Mar 26;15(1):2652. doi: 10.1038/s41467-024-46828-1.
2
Syntaxin 5 determines Weibel-Palade body size and von Willebrand factor secretion by controlling Golgi architecture.Syntaxin 5 通过控制高尔基体结构来决定 Weibel-Palade 体的大小和 von Willebrand 因子的分泌。
Haematologica. 2022 Aug 1;107(8):1827-1839. doi: 10.3324/haematol.2021.280121.
3
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report.

本文引用的文献

1
Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.Syntaxin结合蛋白5和Syntaxin-2基因变异对血管性血友病因子浓度及心血管风险的影响。
Circ Cardiovasc Genet. 2010 Dec;3(6):507-12. doi: 10.1161/CIRCGENETICS.110.957407.
2
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.多个遗传位点与血浆因子 VII、因子 VIII 和血管性血友病因子水平的新关联:CHARGE(基因组流行病学中的心脏和衰老研究队列)联盟。
Circulation. 2010 Mar 30;121(12):1382-92. doi: 10.1161/CIRCULATIONAHA.109.869156. Epub 2010 Mar 15.
3
轻度和中度遗传性出血性疾病系统治疗方法的基础:欧洲血液学协会共识报告
Hemasphere. 2019 Sep 17;3(4):e286. doi: 10.1097/HS9.0000000000000286. eCollection 2019 Oct.
4
The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.遗传学在 1 型血管性血友病发病机制和诊断中的作用。
Curr Opin Hematol. 2019 Sep;26(5):331-335. doi: 10.1097/MOH.0000000000000524.
5
Genetic regulation of plasma von Willebrand factor levels in health and disease.遗传调控健康和疾病状态下的血浆血管性血友病因子水平。
J Thromb Haemost. 2018 Dec;16(12):2375-2390. doi: 10.1111/jth.14304. Epub 2018 Oct 30.
6
Von Willebrand disease in the elderly: clinical perspectives.老年血管性血友病:临床视角。
Clin Interv Aging. 2018 Aug 31;13:1531-1541. doi: 10.2147/CIA.S136931. eCollection 2018.
7
Regulation of plasma von Willebrand factor.血浆血管性血友病因子的调节
F1000Res. 2018 Jan 23;7:96. doi: 10.12688/f1000research.13056.1. eCollection 2018.
8
Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.1型血管性血友病患者中C型凝集素受体CLEC4M的基因变异
PLoS One. 2018 Feb 1;13(2):e0192024. doi: 10.1371/journal.pone.0192024. eCollection 2018.
9
Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.通过小鼠体内的CRISPR/Cas9基因编辑揭示人STXBP5中一个单核苷酸多态性的新型血栓形成功能
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):264-270. doi: 10.1161/ATVBAHA.116.308614. Epub 2016 Dec 29.
10
The nuts and bolts of the platelet release reaction.血小板释放反应的基本要素。
Platelets. 2017 Mar;28(2):129-137. doi: 10.1080/09537104.2016.1240768. Epub 2016 Nov 16.
Low von Willebrand factor: sometimes a risk factor and sometimes a disease.低血管性血友病因子:有时是风险因素,有时是疾病。
Hematology Am Soc Hematol Educ Program. 2009:106-12. doi: 10.1182/asheducation-2009.1.106.
4
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.O血型个体中血管性血友病因子生存期较短,这解释了ABO血型决定簇如何影响血浆血管性血友病因子。
Blood. 2008 Apr 1;111(7):3540-5. doi: 10.1182/blood-2007-11-122945. Epub 2008 Feb 1.
5
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).血浆血管性血友病因子水平在1型血管性血友病诊断中的作用:一项欧洲多中心研究(MCMDM-1VWD)的结果
J Thromb Haemost. 2007 Apr;5(4):715-21. doi: 10.1111/j.1538-7836.2007.02444.x.
6
The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.1型血管性血友病的突变谱:一项加拿大队列研究的结果。
Blood. 2007 Jan 1;109(1):145-54. doi: 10.1182/blood-2006-05-021105..
7
An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.对英国诊断为1型血管性血友病的患者进行血管性血友病因子基因型调查。
Thromb Haemost. 2006 Nov;96(5):630-41.
8
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).在欧洲开展的“1型血管性血友病诊断与管理的分子和临床标志物研究(MCMDM-1VWD)”中,一组历史上被诊断为1型血管性血友病的家族的表型和基因型。
Blood. 2007 Jan 1;109(1):112-21. doi: 10.1182/blood-2006-05-020784. Epub 2006 Sep 19.
9
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.血管性血友病的病理生理学与分类更新:血管性血友病因子小组委员会报告
J Thromb Haemost. 2006 Oct;4(10):2103-14. doi: 10.1111/j.1538-7836.2006.02146.x. Epub 2006 Aug 2.
10
Regulation of Weibel-Palade body exocytosis.魏贝尔-帕拉德小体胞吐作用的调控
Trends Cardiovasc Med. 2005 Nov;15(8):302-8. doi: 10.1016/j.tcm.2005.09.005.